Figure 5. Recovery of alpha2adrenoceptor binding sites in the spinal cord after N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ). Separate groups of rats were administered EEDQ 0, 0.1, 0.2, and 0.3 micro gram *symbol* kg sup -1 subcutaneously, and 3 days later radiolabeled-ligand binding studies were performed. Data are expressed as a percentage of control animals normalized to 100%. Data were analyzed by analysis of variance and post hoc Scheffe test where appropriate. *P < 0.05. n - 4 per group.